Triple Action Serum – 50 ML

Icona London Triple Action Serum 50 ML | Betamethasone Dipropionate, Clotrimazole & Gentamicin Sulphate Topical Serum | Antifungal, Antibacterial & Anti-Inflammatory

Icona London Triple Action Serum – 50 ML is a medicated topical dermatology product formulated with three active ingredients shown on the packaging: Betamethasone Dipropionate, Clotrimazole and Gentamicin Sulphate. The product is positioned around three complementary actions—antifungal, anti-inflammatory and antibacterial—for appropriate skin-treatment applications under professional guidance.

The anti-inflammatory component, betamethasone dipropionate, belongs to the topical corticosteroid class. Betamethasone topical medicines are used to reduce inflammation, redness and itching associated with appropriate corticosteroid-responsive skin conditions. Because corticosteroids can cause unwanted effects when used incorrectly or for excessive periods, application area, frequency and treatment duration should follow the approved product information or healthcare-professional advice.

Clotrimazole provides the antifungal component of the Triple Action Serum. Clotrimazole is an established topical antifungal used for susceptible fungal skin infections, including conditions such as athlete’s foot, ringworm and jock itch in appropriate formulations. This supports the antifungal positioning clearly displayed on the Icona London packaging.

The third component, Gentamicin Sulphate, is an antibacterial antibiotic used topically against susceptible bacteria responsible for certain primary and secondary bacterial skin infections. Its inclusion provides the antibacterial element of the product’s Triple Action formula.

The serum-style liquid format provides an alternative to conventional creams and lotions. A liquid topical formulation can allow convenient application to appropriate affected skin areas where the product has been prescribed or recommended. The 50 ML pack size provided for this listing offers a practical format for controlled topical use.

The packaging also displays “Result in 7 Days.” This should be treated as a product-packaging statement rather than a guaranteed clinical outcome. Treatment response can differ depending on the underlying skin condition, organism involved, treatment adherence and individual response.

For B2C users, the product should only be used according to its complete instructions and appropriate healthcare guidance. Fungal, bacterial and inflammatory skin conditions can sometimes have similar appearances, so self-diagnosing and repeatedly applying a corticosteroid-antibiotic-antifungal combination may be inappropriate.

For B2B buyers, Icona London Triple Action Serum can be positioned for authorized pharmacies, pharmaceutical wholesalers, healthcare distributors, importers and regulated dermatology-product channels, subject to local medicine-registration and dispensing requirements.

The exact concentrations of Betamethasone Dipropionate, Clotrimazole and Gentamicin Sulphate, along with the complete excipient formula, approved age range and prescription classification, are To Be Confirmed from official Icona London regulatory documentation.